Stock Spotlight Archives - Page 116 of 379

MondayMar 21, 2022 1:34 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Creating 360-Degree Music Experience for Artists Worldwide

Friendable (OTC: FDBL) is making a statement with its “anti-label” offerings — Fan Pass Live and the recently acquired Artist Republik. The “anti-label” movement cuts out the contracts and high fees for distribution associated with being signed to record labels, leaving artists in control of their music once more. Released in July 2020, The Fan Pass Live artist platform is an online stage where artists can stream and perform music live for fans, all from a mobile device. The platform also offers artist channels, merchandise and promotion options without signing a recording contract. In January 2022, Friendable completed the acquisition…

FridayMar 18, 2022 2:14 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Laser-Focused on Offering Best and Trusted Digital Payment Solutions

GreenBox (NASDAQ: GBOX), an innovative blockchain ledger fintech company, is guided by the goal to become the prominent, ultimate, best digital payments company globally. To accomplish this, GreenBox is leveraging its experienced, passionate workforce and differentiated, ownable, world-class technology to make people’s lives much easier as well as offer them true payment solutions. According to GBOX Chief Marketing Officer Jacqueline B. Reynolds, who appeared on a January episode of The Wild West Crypto Show, the company’s blockchain-based payment solutions are designed to provide a simple, hassle-free user experience. At the same time, GreenBox offers technology that businesses can use to…

FridayMar 18, 2022 2:01 pm

QualityStocksNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Commercialization Phase of Its Corporate Development, Recognizes First-Ever Revenues

Nemaura Medical (NASDAQ: NMRD) recently announced its Q3 FY 2022 results for the three months ended Dec. 31, 2021. The company reported revenues of $183,628 due to the initial shipments made over the past quarter of sugarBEAT(R) CGM devices to MySugarWatch, the company’s U.K. licensee. The order marked the inaugural revenues in Nemaura Medical’s history, with the company rapidly moving toward monetizing its recent product launches. “The December quarter marked a milestone for Nemaura, as we officially entered the commercialization phase of our corporate development and recognized revenues for the first time in our history,” a recent article quotes Nemaura…

FridayMar 18, 2022 12:58 pm

QualityStocksNewsBreaks – American Cannabis Partners’ Rare Approach Sets It Apart in Competitive Industry

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator contending for first place in the U.S. cannabis industry, relies on proven strategies such as mergers and acquisitions to strengthen its position in a competitive market. For ACP, due diligence is a top priority before acquiring any assets. Its website notes that its sights are set on listings in cannabis-friendly states, cannabis population demand, agricultural zoning, available licenses, and market value. ACP purchases land and equipment in full to keep it debt-free and liquid. After completing acquisitions, the company undertakes cost-effective measures to update and appraise properties to increase market…

FridayMar 18, 2022 12:42 pm

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Confirms Potential of Optioned Gold Properties

StraightUp Resources (CSE: ST) (OTCQB: STUPF), a precious metals explorer, has spent the past year examining the potential for gold exploration on flagship properties it has optioned in Canada’s well-known greenstone belts in Ontario, anticipating persistent demand for the metal worldwide. “Ground magnetic surveys and helicopter-borne high-resolution aerial magnetic surveys have helped confirm the potential of StraightUp’s five gold properties in the Red Lake Mining region, such as ‘multiple areas of high merit and potential mineralization’ reported in November at the Ferdinand Gold Project, which consists of 17 contiguous mining claims covering 7,143 hectares (17,651 acres),” a recent article reads.…

FridayMar 18, 2022 11:39 am

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris(TM) Enabling Users to Learn More in Less Time

Nowigence has developed an off-the-shelf, cloud-based, artificial intelligence (“AI”) platform, called Pluaris(TM), that can successfully handle more than one task at a time. While a recent Forbes article declared multitasking might not be real, Nowigence’s Pluaris is. “Relying on artificial intelligence rather than human intelligence, Pluaris can do a myriad of things simultaneously. The game-changing app automatically monitors public news sources for identified topics of interest while also gathering information together and providing summaries, extracting intelligence and creating graphical analysis. It’s the ultimate multitasking platform,” a recent article reads. “And while Pluaris automates reading and analysis of textual data, the…

FridayMar 18, 2022 11:24 am

QualityStocksNewsBreaks – Red White & Bloom Brands Inc.’s (CSE: RWB) (OTCQX: RWBYF) Acquisition Strategy Spearheading Expansion, Premium Inventory Production

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a premium cannabis brand multistate operator, has been building assets steadily in Michigan, Florida, Illinois, Massachusetts, and Arizona, while working to establish the quality and consistency that wellness consumers seek. The company announced full licensing for manufacturing both medical and adult-use cannabis products in Michigan in January, along with the closing of a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in the city of Warren. A recent article reads: “The manufacturing facility is a key part of RWB’s acquisition strategy for 18 Michigan dispensaries, four cultivation facilities and…

ThursdayMar 17, 2022 3:05 pm

QualityStocksNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Playing Pivotal Role in Renaissance of Psychedelics

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, is among organizations, working alongside researchers at the center of the veritable renaissance of psychedelics. “Mydecine is playing a crucial role in advancing the knowledge of the benefits of psychedelics by developing innovative first- and second-generation novel compounds for the treatment of mental health and addiction and sequentially collaborating with academics to undertake vital clinical research on them. So far, Mydecine has partnered with Johns Hopkins University to launch a clinical trial utilizing psilocybin for smoking cessation. Led…

ThursdayMar 17, 2022 2:44 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Significant Milestone in Advancing Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently participated in the Virtual Investor 2022 Top Picks Conference. The company’s CEO John Climaco provided a corporate presentation and participated in a moderated questions and answer session during the event. Berubicin, a novel anthracycline and the first in its drug class to appear to cross the blood-brain barrier, is CNS Pharmaceuticals’ lead drug candidate. “The company is currently developing treatments using Berubicin for serious brain and central nervous system oncology indications, including glioblastoma…

WednesdayMar 16, 2022 2:25 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, has dedicated itself to developing new therapeutic alternatives for the treatment of conditions with high unmet medical needs. The manufacturing process used by InMed and its recently acquired subsidiary BayMedica is unparalleled in the industry. “There is no ‘one-size-fits-all’ approach to cannabinoid manufacturing, so multiple avenues are required to realize the maximum outcome for the targeted cannabinoid. InMed and BayMedica, like a well-oiled machine, work together using biosynthesis, chemical synthesis and the proprietary IntegraSyn(TM) manufacturing models,” a recent article explains. “Together,…

Site Search

Company Search

Category: Stock Spotlight